You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 28, 2024

CLINICAL TRIALS PROFILE FOR C1 ESTERASE INHIBITOR RECOMBINANT


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for c1 esterase inhibitor recombinant

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00069550 ↗ Independent Studies of Dextromethorphan and of Donepezil Hydrochloride for Rett Syndrome Unknown status Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Phase 3 2004-09-01 Rett syndrome (RTT) is a disorder in which the nervous system does not develop properly. RTT generally affects girls, but there are some boys who have been diagnosed with RTT. Symptoms of RTT include small brain size, poor language skills, repetitive hand movements, and seizures. This study will evaluate the effectiveness of two drugs in treating the symptoms of RTT.
NCT00289211 ↗ C1 Esterase Inhibitor (C1INH-nf) for the Treatment of Acute Hereditary Angioedema (HAE) Attacks Completed Shire Phase 3 2005-03-14 The study objective was to determine the safety and efficacy of C1INH-nf for the treatment of acute HAE attacks.
NCT00292981 ↗ C1 Esterase Inhibitor in Hereditary Angioedema (HAE)(Extension Study) Completed CSL Behring Phase 3 2005-08-01 Hereditary angioedema (HAE) is a rare disorder characterized by congenital lack of functional C1 esterase inhibitor. If not treated adequately, the acute attacks of HAE can be life-threatening and may even result in fatalities, especially in case of involvement of the larynx.The planned extension study is designed to enrol subjects that participated in the pivotal study in order to provide them with C1-INH for treatment of acute HAE attacks for 24 months or until the licensing procedure for C1-INH is finalized, whatever comes first.
NCT00431782 ↗ Study of a New Anticoagulant Drug in Patients With Atrial Fibrillation Completed ARYx Therapeutics Phase 2 2006-12-01 The primary purpose of this study (CLN-504) is to determine the safety and develop a dosing regimen of an investigational anticoagulant drug (ATI-5923) in patients with atrial fibrillation.
NCT00432510 ↗ Pharmacokinetics of C1 Esterase Inhibitor in Hereditary Angioedema Subjects Completed Shire Phase 1 2006-10-09 The study objective was to describe the pharmacokinetics (PK) of one or two doses of C1 esterase inhibitor (C1INH-nf) in hereditary angioedema (HAE) subjects who were not experiencing an HAE attack.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for c1 esterase inhibitor recombinant

Condition Name

Condition Name for c1 esterase inhibitor recombinant
Intervention Trials
Hereditary Angioedema 8
Inflammation 3
Hereditary Angioedema (HAE) 2
Endotoxemia 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for c1 esterase inhibitor recombinant
Intervention Trials
Angioedemas, Hereditary 10
Angioedema 10
Inflammation 3
Acute Kidney Injury 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for c1 esterase inhibitor recombinant

Trials by Country

Trials by Country for c1 esterase inhibitor recombinant
Location Trials
United States 122
Germany 7
Canada 5
Netherlands 5
France 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for c1 esterase inhibitor recombinant
Location Trials
Texas 9
Maryland 7
California 7
Pennsylvania 6
Oklahoma 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for c1 esterase inhibitor recombinant

Clinical Trial Phase

Clinical Trial Phase for c1 esterase inhibitor recombinant
Clinical Trial Phase Trials
Phase 4 2
Phase 3 11
Phase 2/Phase 3 2
[disabled in preview] 13
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for c1 esterase inhibitor recombinant
Clinical Trial Phase Trials
Completed 17
Terminated 5
Not yet recruiting 4
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for c1 esterase inhibitor recombinant

Sponsor Name

Sponsor Name for c1 esterase inhibitor recombinant
Sponsor Trials
Shire 6
Pharming Technologies B.V. 5
University Hospital, Basel, Switzerland 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for c1 esterase inhibitor recombinant
Sponsor Trials
Other 35
Industry 22
NIH 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.